Safety and Efficacy of VDPHL01 in Males and Females With AGA

NCT06527365 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia
AGA
Male Pattern Baldness

Interventions

DRUG: VDPHL01

Sponsor

Veradermics, Inc.